anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Metric

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 79,264
Current window 72,391-72,420
Pages 2,643
Rows per page 30
Component: Metricclear collectionreset all
18 30 60

Component

72,391-72,420 of 79,264

filter-aware
07
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
11
The chart highlights the correlation between CEO tenure/acquisitions and stock performance.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor Loop · Tale Two Worlds1 hit
13
The slide uses the 'Outsiders' framework to establish a benchmark for Valeant's management philosophy.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor Loop · Tale Two Worlds1 hit
23
The chart uses a bridge-like structure to reclassify 85% of revenue as 'durable' by excluding the 15% 'Patent Cliff Rx' portion.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
24
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
25
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
26
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
29
The slide uses a dot-matrix to visualize market presence by product type and region.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
30
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
31
The slide highlights that the durable business represents ~85% of total sales.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
33
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
34
The slide uses media headlines as evidence of the financial risk associated with traditional R&D models.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
37
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
38
The slide uses a waterfall-style comparison to illustrate margin efficiency.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
40
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
46
The slide uses a waterfall-style visual to contrast cost components.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
50
Uses a conceptual line chart to explain the 'patent cliff' impact on reported growth.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
51
The table highlights the performance of 'Total Product Sales' across different periods.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
54
Allergan, Inc. (AGN)Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
55
The slide uses a table to show the vesting schedule of performance share units (PSUs) based on annualized Total Shareholder Return (TSR).Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
60
The slide uses a visual bracket to emphasize the cumulative difference between the two metrics over the three-year period.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
62
The slide uses a bridge-style reconciliation table to justify non-GAAP metrics.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
63
The slide uses a table to contrast GAAP accounting practices with the author's economic view of the company's performance.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor 1 hit
65
The slide uses a dual-axis chart to correlate share price (line) with volume (bars) and Pershing Square's specific purchase activity (dark bars).Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor Loop · Cost Of Inaction1 hit
66
This slide provides factual evidence regarding the accumulation of an economic stake and the subsequent market reaction.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor Loop · Cost Of Inaction1 hit
67
This slide is likely part of a legal or regulatory filing (SEC) documenting market activity.Allergan, Inc. (AGN) · William Ackman
Activist deck Activist investor Loop · Cost Of Inaction1 hit
37
The slide uses a bar chart to compare P&G against a peer group consisting of Church & Dwight, Clorox, Colgate, Kimberly-Clark, L'Oréal, and Unilever.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Impact & Next StepsLoop · Before After1 hit
38
The Procter & Gamble Company (PG)The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Impact & Next StepsLoop · Before After1 hit
42
Slide 41 of a presentation. Includes footnote regarding fiscal year end and dividend assumptions.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Impact & Next Steps1 hit
44
The chart highlights P&G in a lighter blue color compared to the darker blue used for peers.The Procter & Gamble Company (PG) · William Ackman
Conference presentation Activist investor Beat · Impact & Next Steps1 hit